Syros Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Syros Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$27.4M, a 19.4% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$120M, a 15.8% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$129M, a 5.07% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$136M, a 36.7% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$99.4M, a 20.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$129M +$6.89M +5.07% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 -$136M -$36.5M -36.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 -$99.4M -$17.1M -20.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$82.3M -$4.56M -5.86% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$77.7M -$13.4M -20.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$64.3M -$9.61M -17.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 -$54.7M -$6.72M -14% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 -$48M -$18.1M -60.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$29.8M -$16.4M -122% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$13.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.